Prednisolone/Prednisone
- Generic Name
- Prednisolone/Prednisone
A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis
Phase 2
Completed
- Conditions
- Lupus Nephritis
- Interventions
- First Posted Date
- 2010-03-11
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT01085097
- Locations
- 🇺🇸
Teva Investigational Site 1022, Lake Success, New York, United States
🇬🇧Teva Investigational Site 3412, Dudley, United Kingdom
🇨🇦Teva Investigational Site 1114, Winnipeg, Manitoba, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath